114 related articles for article (PubMed ID: 8221778)
21. Molecular characterization of the ligand-receptor interaction of neuropeptide Y.
Ingenhoven N; Beck-Sickinger AG
Curr Med Chem; 1999 Nov; 6(11):1055-66. PubMed ID: 10519913
[TBL] [Abstract][Full Text] [Related]
22. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
Lerch M; Mayrhofer M; Zerbe O
J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
[TBL] [Abstract][Full Text] [Related]
23. [Neuropeptide Y--structure, receptors, effect and its place in psychiatry].
Bobińska K; Szemraj J; Pietras T; Zboralski K; Gałecki P
Psychiatr Pol; 2008; 42(6):889-901. PubMed ID: 19441666
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptide Y is an angiogenic factor in cardiovascular regeneration.
Saraf R; Mahmood F; Amir R; Matyal R
Eur J Pharmacol; 2016 Apr; 776():64-70. PubMed ID: 26875634
[TBL] [Abstract][Full Text] [Related]
25. Novel modified and radiolabelled neuropeptide Y analogues to study Y-receptor subtypes.
Koglin N; Beck-Sickinger AG
Neuropeptides; 2004 Aug; 38(4):153-61. PubMed ID: 15337368
[TBL] [Abstract][Full Text] [Related]
26. Stabilization of alpha-helix in C-terminal fragments of neuropeptide Y.
Yumoto N; Murase S; Hattori T; Yamamoto H; Tatsu Y; Yoshikawa S
Biochem Biophys Res Commun; 1993 Nov; 196(3):1490-5. PubMed ID: 8250906
[TBL] [Abstract][Full Text] [Related]
27. First selective agonist of the neuropeptide Y1-receptor with reduced size.
Zwanziger D; Böhme I; Lindner D; Beck-Sickinger AG
J Pept Sci; 2009 Dec; 15(12):856-66. PubMed ID: 19890892
[TBL] [Abstract][Full Text] [Related]
28. [Neuropeptide Y: its diversity and the apparent contradictoriness of its functions. An analysis of its possible mediated effects].
Koroleva SV; Ashmarin IP
Usp Fiziol Nauk; 2000; 31(1):31-46. PubMed ID: 10752130
[TBL] [Abstract][Full Text] [Related]
29. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
Sautel M; Rudolf K; Wittneben H; Herzog H; Martinez R; Munoz M; Eberlein W; Engel W; Walker P; Beck-Sickinger AG
Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135
[TBL] [Abstract][Full Text] [Related]
30. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
[TBL] [Abstract][Full Text] [Related]
31. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist.
Jois SD; Nagarajarao LM; Prabhakaran M; Balasubramaniam A
J Biomol Struct Dyn; 2006 Apr; 23(5):497-508. PubMed ID: 16494499
[TBL] [Abstract][Full Text] [Related]
32. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing.
Ekstrand AJ; Cao R; Bjorndahl M; Nystrom S; Jonsson-Rylander AC; Hassani H; Hallberg B; Nordlander M; Cao Y
Proc Natl Acad Sci U S A; 2003 May; 100(10):6033-8. PubMed ID: 12730369
[TBL] [Abstract][Full Text] [Related]
33. Neurogenic atherosclerosis mediated by neuropeptide y: hardening of the evidence.
Sobey CG
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1137-9. PubMed ID: 12857715
[No Abstract] [Full Text] [Related]
34. Analogues of neuropeptide Y containing beta-aminocyclopropane carboxylic acids are the shortest linear peptides that are selective for the Y1 receptor.
Koglin N; Zorn C; Beumer R; Cabrele C; Bubert C; Sewald N; Reiser O; Beck-Sickinger AG
Angew Chem Int Ed Engl; 2003 Jan; 42(2):202-5. PubMed ID: 12532350
[No Abstract] [Full Text] [Related]
35. Identification of a Cyanine-Dye Labeled Peptidic Ligand for Y1R and Y4R, Based upon the Neuropeptide Y C-Terminal Analogue, BVD-15.
Liu M; Richardson RR; Mountford SJ; Zhang L; Tempone MH; Herzog H; Holliday ND; Thompson PE
Bioconjug Chem; 2016 Sep; 27(9):2166-75. PubMed ID: 27513006
[TBL] [Abstract][Full Text] [Related]
36. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
[TBL] [Abstract][Full Text] [Related]
37. Sympathetic co-transmission: the coordinated action of ATP and noradrenaline and their modulation by neuropeptide Y in human vascular neuroeffector junctions.
Pablo Huidobro-Toro J; Verónica Donoso M
Eur J Pharmacol; 2004 Oct; 500(1-3):27-35. PubMed ID: 15464018
[TBL] [Abstract][Full Text] [Related]
38. Neuropeptide Y/peptide YY receptor Y2 duplicate in zebrafish with unique introns displays distinct peptide binding properties.
Fällmar H; Sundström G; Lundell I; Mohell N; Larhammar D
Comp Biochem Physiol B Biochem Mol Biol; 2011 Dec; 160(4):166-73. PubMed ID: 21855645
[TBL] [Abstract][Full Text] [Related]
39. A receptor subtype involved in neuropeptide-Y-induced food intake.
Gerald C; Walker MW; Criscione L; Gustafson EL; Batzl-Hartmann C; Smith KE; Vaysse P; Durkin MM; Laz TM; Linemeyer DL; Schaffhauser AO; Whitebread S; Hofbauer KG; Taber RI; Branchek TA; Weinshank RL
Nature; 1996 Jul; 382(6587):168-71. PubMed ID: 8700207
[TBL] [Abstract][Full Text] [Related]
40. GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system.
Lindner D; van Dieck J; Merten N; Mörl K; Günther R; Hofmann HJ; Beck-Sickinger AG
Biochemistry; 2008 Jun; 47(22):5905-14. PubMed ID: 18457425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
